Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel use of staphylococcus enterotoxin A gene

A technology of staphylococcal entero and toxin, which can be used in gene therapy, medical preparations containing active ingredients, antiviral agents, etc., and can solve problems such as weak immunogenicity

Inactive Publication Date: 2010-10-27
INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some antigenic genes are less immunogenic and injection of these vaccines alone does not induce sufficient protective immunity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel use of staphylococcus enterotoxin A gene
  • Novel use of staphylococcus enterotoxin A gene
  • Novel use of staphylococcus enterotoxin A gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1, the preparation of plasmid

[0017] 1. Construction of recombinant plasmid pmSEA containing staphylococcal enterotoxin A gene

[0018] Use upstream primer P1: 5'-cgc ggatcc agcgagaaaagcgaagaaa-3' (underlined base is the recognition site of restriction endonuclease BamH I) and downstream primer P2: 5'-atgaattca gaattc acttgtatataatatAGCaata tgcat-3' (the underlined base is the restriction endonuclease EcoR I recognition site), with the genomic DNA of Staphylococcus aureus standard strain ATCC 13565 as template, PCR amplification of SEA gene, the reaction conditions are: (1 ) 96°C for 10 minutes; (2) 94°C for 60 seconds, 50°C for 90 seconds, 72°C for 90 seconds, a total of 30 cycles; (3) 72°C for 10 minutes. After the reaction, the PCR product was subjected to agarose gel electrophoresis to recover a 702bp target fragment, and then the recovered gene fragment was digested with restriction endonucleases BamH I and EcoR I, and the digested product was clon...

Embodiment 2

[0028] Embodiment 2, pmSEA enhances the immunogenicity of the hepatitis B virus surface antigen DNA vaccine

[0029] Mice: Balb / c, female, 4-6 weeks old.

[0030] Grouping: (1) Empty vector group (pcDNA3), 10 rats; (2) Hepatitis B protein vaccine group (rHBsAg), 10 rats; (3) pS2S group, 10 rats; (4) pS2S+pmSEA adjuvant group, 10 rats .

[0031] Immunization scheme: (1) Empty vector group (pcDNA3): 200ug / piece / time; (2) Hepatitis B protein vaccine group (rHBsAg): 400ng / piece / time; (3) pS2S group: 100ug pS2S+100ug pcDNA3 / time times; (4) pS2S+pmSEA adjuvant group: 100ug pS2S+100ug pmSEA / piece / time.

[0032] Under mouse anesthesia (75mg / kg sodium pentobarbital IP), 50uL samples were injected into the quadriceps muscles of the two hind limbs of the mouse, and then the in vivo gene transfer instrument (Zhejiang Xinzhi Company) was used to shock the injection site. The voltage is 120V / cm, the duration is 2ms, 2 times.

[0033] Number of immunizations: two times in total. After th...

Embodiment 3

[0035] Example 3, pmSEA enhances the immunogenicity of malaria multi-epitope antigen DNA vaccine

[0036] Mice: Balb / c, female, 4-6 weeks old.

[0037] Grouping: (1) Empty vector group (pcDNA3), 6 rats; (2) AWTE plasmid group, 6 rats; (3) AWTE plasmid+pmSEA plasmid adjuvant group, 6 rats.

[0038] Immunization scheme: (1) Empty vector group (pcDNA3): 200ug / piece / time; (2) AWTE plasmid group: 100ug AWTE+100ug pcDNA3 / piece / time; (3) AWTE plasmid+pmSEA plasmid adjuvant group: 100ug AWTE +100ug pmSEA / piece / time.

[0039] Under mouse anesthesia (75mg / kg sodium pentobarbital IP), inject 50ul samples into the quadriceps muscles of the two hind limbs of the mouse respectively, and then use an in vivo gene transfer instrument (Zhejiang Xinzhi Company) to perform electric shock at the injection site, The voltage is 120V / cm, the duration is 2ms, 2 times.

[0040] Number of immunizations: two times in total. After the initial immunization, a booster immunization will be given on the 14...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new use of staphylococcal enterotoxin gene A. An experiment carried out by the author of the invention shows that the staphylococcal enterotoxin gene A can obviously improve the reactivity of animals to DNA vaccines and can be used as an adjuvant for improving the immunogenicity of the DNA vaccines or recombinant subunit vaccines. The staphylococcal enterotoxin gene A can improve the immunogenicity of various DNA vaccines, such as HBV surface antigen DNA vaccine and malaria multi-epitope antigen DNA vaccine, etc., has broad spectrum, and is a rare adjuvant for improving the immunogenicity of the DNA vaccines. Therefore, the staphylococcal enterotoxin gene A has great significance in the production and the application of the DAN vaccines and the recombinant subunit vaccines.

Description

[0001] This application is a divisional application with the application number 200510068114.0, the application date is April 26, 2005, and the invention creation title is "New Application of Staphylococcal Enterotoxin A Gene and Its Encoded Protein". technical field [0002] The present invention relates to a new application of the staphylococcal enterotoxin A gene and its encoded protein, in particular to the use of the staphylococcal enterotoxin A gene as an adjuvant for enhancing the immunogenicity of DNA vaccines and the encoded protein of the gene as a recombinant subunit for enhancing the immunogenicity Use in adjuvants. Background technique [0003] Staphylococcal enterotoxin A (staphylococcal enterotoxin A, SEA) is a member of the staphylococcal enterotoxin family produced by Staphylococcus aureus and is one of the most effective T cell activating factors. SEA is a protein molecule containing 233 amino acid residues, rich in serine (S), threonine (T) and aspartic ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/39A61K48/00A61P31/20A61P1/16A61P33/06
CPCY02A50/30
Inventor 马清钧靳彦文胥全彬曹诚
Owner INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com